# Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)

> **NCT00800566** · PHASE1 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Leukemia
- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Oral Clofarabine

## Key facts

- **NCT ID:** NCT00800566
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor terminated.
- **Last updated:** 2012-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800566, "Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00800566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*